Trial intelligence / Profile preview

Integrated traditional Chinese and western medicine for elderly hypertension

ChiCTR-TRC-10001128Phase 4Completed

Sponsor
Xiyuan Hospital
Start
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of nifedipine, enalapril and indapamide in hypertension (HTN) (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Ambulatory blood pressure. Started Jun 2008; status: completed.

02

Drugs

nifedipineenalaprilindapamide
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on ChiCTR-TRC-10001128.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10001128.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call